Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 4 (April)

1. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.
   J Clin Oncol, 25(10): 1239-46. [Abstract] [Full-text]
2. Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.
   J Clin Oncol, 25(10): 1232-8. [Abstract] [Full-text]
3. The influence of HRT on technical recall in the UK Breast Screening Programme: are pain, compression force, and compressed breast thickness contributing factors?
   Clin Radiol, 62(5): 439-46. [Abstract] [Full-text]
4. Transcutaneous electrical nerve stimulation vs. transcutaneous spinal electroanalgesia for chronic pain associated with breast cancer treatments.
   J Pain Symptom Manage, 33(4): 410-9. [Abstract] [Full-text]
5. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy.
   J Pain Symptom Manage, 33(4): 398-409. [Abstract] [Full-text]
6. Human chorionic gonadotropin (hCG) and prevention of breast cancer.
   Mol Cell Endocrinol, 269(1): 93-8. [Abstract] [Full-text]
7. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial.
   Psychooncology, 16(4): 277-86. [Abstract] [Full-text]
8. Prevention of venous thromboembolism in surgical patients with breast cancer.
   Br J Surg, 94(4): 412-20. [Abstract] [Full-text]
9. Definition of a direct extracellular interaction between Met and E-cadherin.
   Cell Biol Int, 31(4): 366-73. [Abstract] [Full-text]
10. The role of self-reported stress in the development of breast cancer and prostate cancer: a prospective cohort study of employed males and females with 30 years of follow-up.
    Eur J Cancer, 43(6): 1060-5. [Abstract] [Full-text]
11. Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.
    Int J Cancer, 120(10): 2061-7. [Abstract] [Full-text]
12. A new platinum complex of triazine demonstrates G1 arrest with novel biological profile in human breast cancer cell line, MDA-MB-468.
    Bioorg Med Chem Lett, 17(8): 2139-45. [Abstract] [Full-text]
13. Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma.
    Vaccine, 25(16): 3022-31. [Abstract] [Full-text]
14. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review.
    Eur J Cancer, 43(6): 993-1001. [Abstract] [Full-text]
15. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
    J Surg Res, 139(1): 36-44. [Abstract] [Full-text]
16. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.
    Int J Cancer, 120(10): 2086-95. [Abstract] [Full-text]
17. A retrospective study of the effect of participation in screening mammography on the use of chemotherapy and breast conserving surgery.
    Int J Cancer, 120(10): 2185-90. [Abstract] [Full-text]
18. Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins.
    Int J Cancer, 120(10): 2078-85. [Abstract] [Full-text]
19. Breast tumours following combined hormone replacement therapy express favourable prognostic factors.
    Int J Cancer, 120(10): 2202-7. [Abstract] [Full-text]
20. Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.
    Int J Cancer, 120(10): 2127-34. [Abstract] [Full-text]
21. A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships.
    Psychooncology, 16(4): 320-8. [Abstract] [Full-text]
22. Standardized audiotape versus recorded consultation to enhance informed consent to a clinical trial in breast oncology.
    Psychooncology, 16(4): 371-6. [Abstract] [Full-text]
23. Association of information satisfaction, psychological distress and monitoring coping style with post-decision regret following breast reconstruction.
    Psychooncology, 16(4): 342-51. [Abstract] [Full-text]
24. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
    Am J Obstet Gynecol, 196(4): 342.e1-9. [Abstract] [Full-text]
25. Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
    Am J Obstet Gynecol, 196(4): e6-9. [Abstract] [Full-text]
26. High-resolution CT by diffraction-enhanced x-ray imaging: mapping of breast tissue samples and comparison with their histo-pathology.
    Phys Med Biol, 52(8): 2197-211. [Abstract] [Full-text]
27. Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer.
    Clin Cancer Res, 13(7): 2061-7. [Abstract] [Full-text]
28. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Clin Cancer Res, 13(7): 2014-22. [Abstract] [Full-text]
29. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Clin Cancer Res, 13(7): 1987-94. [Abstract] [Full-text]
30. Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities.
    Clin Cancer Res, 13(7): 1950-4. [Abstract] [Full-text]
31. The evolution of the conservative approach to breast cancer.
    Breast, 16(2): 120-9. [Abstract] [Full-text]
32. Breast cancer awareness and practice of breast self examination among primary health care nurses: influencing factors and effects of an in-service education.
    J Clin Nurs, 16(4): 707-15. [Abstract] [Full-text]
33. Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer: an increase in cell number at completion of therapy is a predictor of early relapse.
    Breast, 16(2): 211-8. [Abstract] [Full-text]
34. Nonproliferative epithelial alteration and expression of estrogen receptor and Ki67 in the contralateral breast of women treated with tamoxifen for breast cancer.
    Breast, 16(2): 197-203. [Abstract] [Full-text]
35. Sentinel node biopsy in non-palpable breast cancer and in patients with a previous diagnostic excision.
    Eur J Surg Oncol, 33(3): 276-80. [Abstract] [Full-text]
36. A pilot study to evaluate the impact of involving breast cancer patients in the multidisciplinary discussion of their disease and treatment plan.
    Breast, 16(2): 178-89. [Abstract] [Full-text]
37. Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen.
    Breast, 16(2): 204-10. [Abstract] [Full-text]
38. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
    Eur J Surg Oncol, 33(3): 285-93. [Abstract] [Full-text]
39. Axillary ultrasound scanning in the follow-up of breast cancer patients undergoing sentinel node biopsy.
    Breast, 16(2): 190-6. [Abstract] [Full-text]
40. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Eur J Surg Oncol, 33(3): 294-300. [Abstract] [Full-text]
41. Doughnut mastopexy lumpectomy versus standard lumpectomy in breast cancer surgery: a prospective study.
    Eur J Surg Oncol, 33(3): 301-6. [Abstract] [Full-text]
42. Atypical presentations of screen-detected DCIS Implications for pre-operative assessment and surgical intervention.
    Breast, 16(2): 161-71. [Abstract] [Full-text]
43. Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women.
    Breast, 16(2): 172-7. [Abstract] [Full-text]
44. Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer.
    Eur J Surg Oncol, 33(3): 281-4. [Abstract] [Full-text]
45. How relevant is breast cancer screening in the Asia/Pacific region?
    Breast, 16(2): 113-9. [Abstract] [Full-text]
46. What is a positive sentinel lymph node in a breast cancer patient? A practical approach.
    Breast, 16(2): 152-60. [Abstract] [Full-text]
47. Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion.
    Breast, 16(2): 146-51. [Abstract] [Full-text]
48. Comparison between breast volume measurement using 3D surface imaging and classical techniques.
    Breast, 16(2): 137-45. [Abstract] [Full-text]
49. Management of the axilla in women with breast cancer.
    Breast, 16(2): 130-6. [Abstract] [Full-text]
50. Use of tamoxifen in pT1a-pT1b, pN0 breast cancer.
    Eur J Surg Oncol, 33(3): 271-5. [Abstract] [Full-text]
51. Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.
    J Natl Cancer Inst, 99(7): 516-25. [Abstract] [Full-text]
52. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
    J Natl Cancer Inst, 99(7): 506-15. [Abstract] [Full-text]
53. Meat consumption and risk of breast cancer in the UK Women's Cohort Study.
    Br J Cancer, 96(7): 1139-46. [Abstract] [Full-text]
54. Predicted trends in long-term breast cancer survival in England and Wales.
    Br J Cancer, 96(7): 1135-8. [Abstract] [Full-text]
55. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis.
    Br J Cancer, 96(7): 1092-100. [Abstract] [Full-text]
56. Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer.
    Int J Cancer, 120(11): 2331-8. [Abstract] [Full-text]
57. NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration.
    Int J Cancer, 120(11): 2411-7. [Abstract] [Full-text]
58. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: cochrane review.
    Br J Cancer, 96(7): 1025-9. [Abstract] [Full-text]
59. Breast cancer survivors' supportive care needs 2-10 years after diagnosis.
    Support Care Cancer, 15(5): 515-23. [Abstract] [Full-text]
60. Epithelial displacement during breast needle core biopsy causes diagnostic difficulties in subsequent surgical excision specimens.
    J Clin Pathol, 60(4): 373-6. [Abstract] [Full-text]
61. Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.
    J Clin Pathol, 60(4): 397-404. [Abstract] [Full-text]
62. Influence of computer-aided detection on performance of screening mammography.
    N Engl J Med, 356(14): 1399-409. [Abstract] [Full-text]
63. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
    Cancer Res, 67(7): 3412-21. [Abstract] [Full-text]
64. Active induction of tumor-specific IgE antibodies by oral mimotope vaccination.
    Cancer Res, 67(7): 3406-11. [Abstract] [Full-text]
65. A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression.
    Cancer Res, 67(7): 3337-44. [Abstract] [Full-text]
66. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion.
    Cancer Res, 67(7): 3117-26. [Abstract] [Full-text]
67. A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
    Cancer Res, 67(7): 2951-6. [Abstract] [Full-text]
68. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
    Cancer Res, 67(7): 2938-43. [Abstract] [Full-text]
69. High HSP90 expression is associated with decreased survival in breast cancer.
    Cancer Res, 67(7): 2932-7. [Abstract] [Full-text]
70. CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.
    Mol Hum Reprod, 13(4): 231-6. [Abstract] [Full-text]
71. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk.
    Hum Genet, 121(3): 483-90. [Abstract] [Full-text]
72. Placement technique and the early complications of balloon breast brachytherapy: Magee-Womens Hospital experience.
    Am J Clin Oncol, 30(2): 152-5. [Abstract] [Full-text]
73. Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer.
    Am J Clin Oncol, 30(2): 146-51. [Abstract] [Full-text]
74. Activity and tolerability of a combined palliative chemotherapy with mitomycin C, folinate, and 5-Fluorouracil in patients with advanced breast cancer after intensive pretreatment: a retrospective analysis.
    Am J Clin Oncol, 30(2): 139-45. [Abstract] [Full-text]
75. A phase II trial of vinorelbine and pegylated liposomal doxorubicin in patients with pretreated metastatic breast cancer.
    Am J Clin Oncol, 30(2): 133-8. [Abstract] [Full-text]
76. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.
    Am J Clin Oncol, 30(2): 126-32. [Abstract] [Full-text]
77. Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer: an Eastern Cooperative Oncology Group Intergroup Study (E3185).
    Am J Clin Oncol, 30(2): 113-25. [Abstract] [Full-text]
78. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells.
    Plast Reconstr Surg, 119(5): 1409-22; discussion 1423-4. [Abstract] [Full-text]
79. Induction of apoptosis in human breast adenocarcinoma MCF-7 cells by pterocarnin A from the bark of Pterocarya stenoptera via the Fas-mediated pathway.
    Anticancer Drugs, 18(5): 555-62. [Abstract] [Full-text]
80. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
    Am J Surg Pathol, 31(4): 501-8. [Abstract] [Full-text]
81. Persistent pain following postmastectomy breast reconstruction: long-term effects of type and timing of surgery.
    Ann Plast Surg, 58(4): 371-6. [Abstract] [Full-text]
82. Dietary intake and development of a quantitative food-frequency questionnaire for the Barbados National Cancer Study.
    Public Health Nutr, 10(5): 464-70. [Abstract] [Full-text]
83. Identification of a series of tetrahydroisoquinoline derivatives as potential therapeutic agents for breast cancer.
    Bioorg Med Chem Lett, 17(9): 2581-9. [Abstract] [Full-text]
84. Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography.
    Semin Nucl Med, 37(3): 146-53. [Abstract] [Full-text]
85. Meta-analysis of BRCA1 and BRCA2 penetrance.
    J Clin Oncol, 25(11): 1329-33. [Abstract] [Full-text]
86. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors.
    Cancer Epidemiol Biomarkers Prev, 16(4): 775-82. [Abstract] [Full-text]
87. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
    Cancer Epidemiol Biomarkers Prev, 16(4): 769-74. [Abstract] [Full-text]
88. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Cancer Epidemiol Biomarkers Prev, 16(4): 763-8. [Abstract] [Full-text]
89. Detecting an association between socioeconomic status and late stage breast cancer using spatial analysis and area-based measures.
    Cancer Epidemiol Biomarkers Prev, 16(4): 756-62. [Abstract] [Full-text]
90. IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States.
    Cancer Epidemiol Biomarkers Prev, 16(4): 747-55. [Abstract] [Full-text]
91. Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.
    Cancer Epidemiol Biomarkers Prev, 16(4): 740-6. [Abstract] [Full-text]
92. Older breast cancer survivors: factors associated with change in emotional well-being.
    J Clin Oncol, 25(11): 1334-40. [Abstract] [Full-text]
93. Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information.
    Hum Mutat, 28(5): 477-85. [Abstract] [Full-text]
94. Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations: a meta-analytic approach.
    Stat Med, 26(8): 1775-87. [Abstract] [Full-text]
95. Inducing a mode of NK-resistance to suppression by stress and surgery: a potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis.
    Brain Behav Immun, 21(4): 395-408. [Abstract] [Full-text]
96. Three methods for minimally important difference: no relationship was found with the net proportion of patients improving.
    J Clin Epidemiol, 60(5): 448-55. [Abstract] [Full-text]
97. Patient information preferences among breast and prostate cancer patients.
    Australas Radiol, 51(2): 154-8. [Abstract] [Full-text]
98. Metastases to the breast: a review of 33 cases.
    Australas Radiol, 51(2): 133-8. [Abstract] [Full-text]
99. Effect of selected phytochemicals and apple extracts on NF-kappaB activation in human breast cancer MCF-7 cells.
    J Agric Food Chem, 55(8): 3167-73. [Abstract] [Full-text]
100. Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor.
     Cancer Sci, 98(5): 644-51. [Abstract] [Full-text]
101. Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells.
     Cancer Sci, 98(5): 692-7. [Abstract] [Full-text]
102. Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers.
     Cancer Sci, 98(4): 484-90. [Abstract] [Full-text]
103. Preeclampsia, pregnancy-related hypertension, and breast cancer risk.
     Am J Epidemiol, 165(9): 1007-14. [Abstract] [Full-text]
104. Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine.
     Cancer Lett, 250(2): 311-22. [Abstract] [Full-text]
105. Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK.
     Cancer Lett, 250(2): 220-8. [Abstract] [Full-text]
106. Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells.
     Cancer Lett, 250(2): 229-36. [Abstract] [Full-text]
107. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.
     Nature, 446(7137): 765-70. [Abstract] [Full-text]
108. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
     Pharmacogenet Genomics, 17(5): 331-8. [Abstract] [Full-text]
109. Synthetic retinoid fenretinide in breast cancer chemoprevention.
     Expert Rev Anticancer Ther, 7(4): 423-32. [Abstract] [Full-text]
110. ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells.
     Oncogene, 26(17): 2407-22. [Abstract] [Full-text]
111. Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells.
     Oncogene, 26(17): 2459-70. [Abstract] [Full-text]
112. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005.
     BMC Womens Health, 7: 4. [Abstract] [Full-text]
113. Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study.
     Fertil Steril, 87(4): 978-81. [Abstract] [Full-text]
114. Occupational exposures and breast cancer among women textile workers in Shanghai.
     Epidemiology, 18(3): 383-92. [Abstract] [Full-text]
115. Cooked meat and risk of breast cancer--lifetime versus recent dietary intake.
     Epidemiology, 18(3): 373-82. [Abstract] [Full-text]
116. Contrast-enhanced breast magnetic resonance imaging: the surgical perspective.
     Am J Surg, 193(5): 600-5; discussion 605. [Abstract] [Full-text]
117. The impact of nodal isolated tumor cells on survival of breast cancer patients.
     Am J Surg, 193(5): 571-3; discussion 573-4. [Abstract] [Full-text]
118. Measuring surgeon performance of sentinel lymph node biopsy in breast cancer treatment by cumulative sum analysis.
     Am J Surg, 193(5): 556-9; discussion 560. [Abstract] [Full-text]
119. Prognostic significance of reactivation of telomerase in breast core biopsy specimens.
     Am J Surg, 193(5): 547-50; discussion 550. [Abstract] [Full-text]
120. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
     Acad Radiol, 14(5): 561-73. [Abstract] [Full-text]
121. Comparison of three methods to increase knowledge about breast cancer and breast cancer screening in screening mammography patients.
     Acad Radiol, 14(5): 553-60. [Abstract] [Full-text]
122. Perfusion CT of breast carcinoma: arterial perfusion of nonscirrhous carcinoma was higher than that of scirrhous carcinoma.
     Acad Radiol, 14(5): 547-52. [Abstract] [Full-text]
123. Digital mammography: comparative performance of color LCD and monochrome CRT displays.
     Acad Radiol, 14(5): 539-46. [Abstract] [Full-text]
124. Computer-aided mass detection based on ipsilateral multiview mammograms.
     Acad Radiol, 14(5): 530-8. [Abstract] [Full-text]
125. Tissue Doppler and strain imaging for evaluating tissue elasticity of breast lesions.
     Acad Radiol, 14(5): 522-9. [Abstract] [Full-text]
126. Fractal analysis of mammographic parenchymal patterns in breast cancer risk assessment.
     Acad Radiol, 14(5): 513-21. [Abstract] [Full-text]
127. Cell blocks of breast FNAs frequently allow diagnosis of invasion or histological classification of proliferative changes.
     Diagn Cytopathol, 35(5): 263-9. [Abstract] [Full-text]
128. A metastatic renal carcinoid tumor presenting as breast mass: a diagnostic dilemma.
     Diagn Cytopathol, 35(5): 306-10. [Abstract] [Full-text]
129. Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas.
     J Cell Biochem, 101(1): 68-79. [Abstract] [Full-text]
130. Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancer.
     Cytometry A, 71(5): 273-85. [Abstract] [Full-text]
131. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3).
     Br J Cancer, 96(8): 1253-7. [Abstract] [Full-text]
132. Initial experience with laparoscopic inferior epigastric vessel ligation for delayed transverse rectus abdominus musculocutaneous flap breast reconstruction.
     Arch Surg, 142(4): 362-4. [Abstract] [Full-text]
133. Sonographic hematoma-guided vs wire-localized lumpectomy for breast cancer: a comparison of margins and volume of resection.
     Arch Surg, 142(4): 343-6. [Abstract] [Full-text]
134. The p53 codon 72 proline allele is endowed with enhanced cell-death inducing potential in cancer cells exposed to hypoxia.
     Br J Cancer, 96(8): 1302-8. [Abstract] [Full-text]
135. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
     Br J Cancer, 96(8): 1204-15. [Abstract] [Full-text]
136. Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years.
     Br J Cancer, 96(8): 1197-203. [Abstract] [Full-text]
137. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
     Life Sci, 80(20): 1873-81. [Abstract] [Full-text]
138. High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer.
     Br J Cancer, 96(8): 1258-64. [Abstract] [Full-text]
139. Interpretation of microarray data in cancer.
     Br J Cancer, 96(8): 1155-8. [Abstract] [Full-text]
140. The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer.
     Int J Cancer, 120(12): 2635-42. [Abstract] [Full-text]
141. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses.
     Int J Cancer, 120(12): 2696-703. [Abstract] [Full-text]
142. Prognostic role of syncytin expression in breast cancer.
     Hum Pathol, 38(5): 726-31. [Abstract] [Full-text]
143. Plasma and tissue pharmacokinetics of epirubicin and Paclitaxel in patients receiving neoadjuvant chemotherapy for locally advanced primary breast cancer.
     Clin Pharmacol Ther, 81(5): 659-68. [Abstract] [Full-text]
144. Smoking and survival after breast cancer diagnosis.
     Int J Cancer, 120(12): 2672-7. [Abstract] [Full-text]
145. A retrospective analysis of patient satisfaction with immediate postmastectomy breast reconstruction: comparison of three common procedures.
     Plast Reconstr Surg, 119(6): 1669-76; discussion 1677-8. [Abstract] [Full-text]
146. Use of AlloDerm in primary nipple reconstruction to improve long-term nipple projection.
     Plast Reconstr Surg, 119(6): 1663-8. [Abstract] [Full-text]
147. Periareolar skin-sparing mastectomy and latissimus dorsi flap with biodimensional expander implant reconstruction: surgical planning, outcome, and complications.
     Plast Reconstr Surg, 119(6): 1637-49; discussion 1650-2. [Abstract] [Full-text]
148. Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer.
     J Natl Cancer Inst, 99(8): 628-38. [Abstract] [Full-text]
149. Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways.
     J Natl Cancer Inst, 99(8): 616-27. [Abstract] [Full-text]
150. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
     Cancer Res, 67(8): 3955-62. [Abstract] [Full-text]
151. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
     Cancer Res, 67(8): 3945-54. [Abstract] [Full-text]
152. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation.
     Cancer Res, 67(8): 3845-52. [Abstract] [Full-text]
153. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
     Cancer Res, 67(8): 3734-40. [Abstract] [Full-text]
154. A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African Americans.
     Cancer Res, 67(8): 3565-8. [Abstract] [Full-text]
155. Elucidating the function of secreted maspin: inhibiting cathepsin D-mediated matrix degradation.
     Cancer Res, 67(8): 3535-9. [Abstract] [Full-text]
156. Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species.
     Cancer Res, 67(8): 3512-7. [Abstract] [Full-text]
157. Prognostic implications of HER-2 status in steroid receptor-positive, lymph node-negative breast carcinoma.
     Am J Clin Pathol, 127(5): 780-6. [Abstract] [Full-text]
158. Lung metastasis genes couple breast tumor size and metastatic spread.
     Proc Natl Acad Sci U S A, 104(16): 6740-5. [Abstract] [Full-text]
159. Analysis of PALB2/FANCN-associated breast cancer families.
     Proc Natl Acad Sci U S A, 104(16): 6788-93. [Abstract] [Full-text]
160. Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.
     BMC Cancer, 7: 59. [Abstract] [Full-text]
161. The decrease in breast-cancer incidence in 2003 in the United States.
     N Engl J Med, 356(16): 1670-4. [Abstract] [Full-text]
162. Preoperative chemotherapy for women with operable breast cancer.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
163. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
164. Cancer genetic risk assessment for individuals at risk of familial breast cancer.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
165. Breast cancer presenting as unilateral arm edema.
     J Gen Intern Med, 22(5): 675-6. [Abstract] [Full-text]
166. Standardization of HER2 testing: results of an international proficiency-testing ring study.
     Mod Pathol, 20(5): 584-91. [Abstract] [Full-text]
167. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
     J Clin Oncol, 25(12): 1482-8. [Abstract] [Full-text]
168. Regulation of clustered gene expression by cofactor of BRCA1 (COBRA1) in breast cancer cells.
     Oncogene, 26(18): 2543-53. [Abstract] [Full-text]
169. Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
     Oncogene, 26(18): 2585-94. [Abstract] [Full-text]
170. Membrane-initiated steroid signaling action of estrogen and breast cancer.
     Semin Reprod Med, 25(3): 187-97. [Abstract] [Full-text]
171. Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.
     Med Care, 45(5): 431-9. [Abstract] [Full-text]
172. Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureus.
     Biochem Biophys Res Commun, 357(1): 282-8. [Abstract] [Full-text]
173. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
     Cell Signal, 19(6): 1290-300. [Abstract] [Full-text]
174. Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.
     Endocrinology, 148(5): 2532-41. [Abstract] [Full-text]
175. Diffuse cranial nerve and cauda equina lesions associated with breast cancer.
     Clin Imaging, 31(3): 202-5. [Abstract] [Full-text]
176. Value of MRI in the surgical planning of invasive lobular breast carcinoma: a prospective and a retrospective study of 57 cases: comparison with physical examination, conventional imaging, and histology.
     Clin Imaging, 31(3): 155-61. [Abstract] [Full-text]
177. Patients' view on intraoperative diagnosis of sentinel nodes in breast cancer: is it an automatic choice?
     Int J Surg, 5(2): 76-80. [Abstract] [Full-text]
178. Respiratory motion of the heart and positional reproducibility under active breathing control.
     Int J Radiat Oncol Biol Phys, 68(1): 253-8. [Abstract] [Full-text]
179. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views.
     Int J Radiat Oncol Biol Phys, 68(1): 66-72. [Abstract] [Full-text]
180. Mammary and extramammary Paget's disease.
     J Eur Acad Dermatol Venereol, 21(5): 581-90. [Abstract] [Full-text]
181. Multivariate logistic regression for familial aggregation in age at disease onset.
     Lifetime Data Anal, 13(2): 191-209. [Abstract] [Full-text]
182. A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer.
     Eur J Cancer, 43(7): 1153-60. [Abstract] [Full-text]
183. Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata.
     Food Chem Toxicol, 45(7): 1107-15. [Abstract] [Full-text]
184. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.
     Eur J Cancer, 43(7): 1117-24. [Abstract] [Full-text]
185. Intact Mre11/Rad50/Nbs1 complex predicts good response to radiotherapy in early breast cancer.
     Int J Radiat Oncol Biol Phys, 68(1): 50-8. [Abstract] [Full-text]
186. Long-term clinical outcomes of whole-breast irradiation delivered in the prone position.
     Int J Radiat Oncol Biol Phys, 68(1): 73-81. [Abstract] [Full-text]
187. Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients.
     Int J Radiat Oncol Biol Phys, 68(1): 82-93. [Abstract] [Full-text]
188. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
     Mol Biol Cell, 18(5): 1768-80. [Abstract] [Full-text]
189. The reversed social gradient: higher breast cancer mortality in the higher educated compared to lower educated. A comparison of 11 European populations during the 1990s.
     Eur J Cancer, 43(7): 1200-7. [Abstract] [Full-text]
190. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.
     Int J Radiat Oncol Biol Phys, 68(1): 59-65. [Abstract] [Full-text]
191. Adjuvant endocrine therapy for early breast cancer.
     Cancer Lett, 251(1): 17-27. [Abstract] [Full-text]
192. Prediction in breast cancer of the extent of axillary node involvement from the size and lymphovascular invasion status of the primary tumour: medico-legal considerations.
     Eur J Surg Oncol, 33(4): 435-7. [Abstract] [Full-text]
193. Predictors of axillary lymph node metastasis in breast cancer: a systematic review.
     Eur J Surg Oncol, 33(4): 409-19. [Abstract] [Full-text]
194. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.
     Eur J Surg Oncol, 33(4): 438-43. [Abstract] [Full-text]
195. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.
     Eur J Surg Oncol, 33(4): 430-4. [Abstract] [Full-text]
196. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
     Eur J Surg Oncol, 33(4): 424-9. [Abstract] [Full-text]
197. The significance of the site of recurrence to subsequent breast cancer survival.
     Eur J Surg Oncol, 33(4): 420-3. [Abstract] [Full-text]
198. Language and use of cancer screening services among border and non-border Hispanic Texas women.
     Ethn Health, 12(3): 245-63. [Abstract] [Full-text]
199. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
     Curr Eye Res, 32(4): 345-52. [Abstract] [Full-text]
200. Mammographic features of local recurrence after conservative surgery and radiation therapy: comparison with that of the primary tumor.
     Acta Radiol, 48(4): 390-7. [Abstract] [Full-text]
201. Induced and spontaneous abortion and incidence of breast cancer among young women: a prospective cohort study.
     Arch Intern Med, 167(8): 814-20. [Abstract] [Full-text]
202. The experience of massage during chemotherapy treatment in breast cancer patients.
     Clin Nurs Res, 16(2): 85-99; discussion 100-2. [Abstract] [Full-text]
203. Identification of a robust gene signature that predicts breast cancer outcome in independent data sets.
     BMC Cancer, 7: 61. [Abstract] [Full-text]
204. Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes.
     Maturitas, 57(1): 50-5. [Abstract] [Full-text]
205. Primary prevention of breast cancer: new approaches.
     Maturitas, 57(1): 39-41. [Abstract] [Full-text]
206. Androgens and the breast.
     Maturitas, 57(1): 47-9. [Abstract] [Full-text]
207. Risk and risk assessment for breast cancer: molecular and clinical aspects.
     Maturitas, 57(1): 56-60. [Abstract] [Full-text]
208. Breast cancer: are oestrogen metabolites carcinogenic?
     Maturitas, 57(1): 42-6. [Abstract] [Full-text]
209. Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method.
     Proteomics, 7(8): 1188-96. [Abstract] [Full-text]
210. WHI risks: any relevance to menopause management?
     Maturitas, 57(1): 6-10. [Abstract] [Full-text]
211. Response of chronic hypoxic cells to low dose-rate irradiation.
     Int J Radiat Biol, 83(5): 331-45. [Abstract] [Full-text]
212. Induction of adaptive Anti-HER2/neu immune responses in a Phase 1B/2 trial of 2B1 bispecific murine monoclonal antibody in metastatic breast cancer (E3194): a trial coordinated by the Eastern Cooperative Oncology Group.
     J Immunother (1997), 30(4): 455-67. [Abstract] [Full-text]
213. Primary breast lymphoma: the role of mastectomy and the importance of lymph node status.
     Ann Surg, 245(5): 784-9. [Abstract] [Full-text]
214. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care.
     Ann Surg, 245(5): 665-71. [Abstract] [Full-text]
215. Breast cancer detection rate: designing imaging trials to demonstrate improvements.
     Radiology, 243(2): 360-7. [Abstract] [Full-text]
216. Epigenetic reversion of breast carcinoma phenotype is accompanied by changes in DNA sequestration as measured by AluI restriction enzyme.
     Am J Pathol, 170(5): 1739-49. [Abstract] [Full-text]
217. Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity.
     Am J Pathol, 170(5): 1546-60. [Abstract] [Full-text]
218. Loss of fibulin-2 expression is associated with breast cancer progression.
     Am J Pathol, 170(5): 1535-45. [Abstract] [Full-text]
219. Using a community-based outreach program to improve breast health awareness among women in Hong Kong.
     Public Health Nurs, 24(3): 265-73. [Abstract] [Full-text]
220. Insights from transgenic mouse models of ERBB2-induced breast cancer.
     Nat Rev Cancer, 7(5): 389-97. [Abstract] [Full-text]
221. CAD systems for mammography: a real opportunity? A review of the literature.
     Radiol Med (Torino), 112(3): 329-53. [Abstract] [Full-text]
222. Adjunctive diagnostic value of ultrasonography evaluation in patients with suspected ductal breast disease.
     Radiol Med (Torino), 112(3): 354-65. [Abstract] [Full-text]
223. Radiography of the surgical specimen in early stage breast lesions: diagnostic reliability in the analysis of the resection margins.
     Radiol Med (Torino), 112(3): 366-76. [Abstract] [Full-text]
224. Electromagnetic breast imaging: results of a pilot study in women with abnormal mammograms.
     Radiology, 243(2): 350-9. [Abstract] [Full-text]
225. Microscopic pulmonary neoplastic emboli: report of a case with respiratory failure but normal imaging.
     Prim Care Respir J, 16(2): 115-7. [Abstract] [Full-text]
226. Digital mammography: effects of reduced radiation dose on diagnostic performance.
     Radiology, 243(2): 396-404. [Abstract] [Full-text]
227. A mathematical model of breast cancer development, local treatment and recurrence.
     J Theor Biol, 246(2): 245-59. [Abstract] [Full-text]
228. The clinical significance of lobular neoplasia on breast core biopsy.
     Am J Surg Pathol, 31(5): 717-23. [Abstract] [Full-text]
229. Diagnostic value of ductoscopy in the diagnosis of nipple discharge and intraductal proliferations in comparison to standard methods.
     Onkologie, 30(5): 243-8. [Abstract] [Full-text]
230. Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells.
     Mol Pharmacol, 71(5): 1233-40. [Abstract] [Full-text]
231. Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.
     Carcinogenesis, 28(5): 1079-86. [Abstract] [Full-text]
232. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
     Carcinogenesis, 28(5): 1067-73. [Abstract] [Full-text]
233. Green tea and the prevention of breast cancer: a case-control study in Southeast China.
     Carcinogenesis, 28(5): 1074-8. [Abstract] [Full-text]
234. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
     Carcinogenesis, 28(5): 1040-5. [Abstract] [Full-text]
235. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
     Carcinogenesis, 28(5): 1000-7. [Abstract] [Full-text]
236. miR-21-mediated tumor growth.
     Oncogene, 26(19): 2799-803. [Abstract] [Full-text]
237. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
     Oncogene, 26(19): 2791-8. [Abstract] [Full-text]
238. Physical activity and breast cancer risk among women in the southwestern United States.
     Ann Epidemiol, 17(5): 342-53. [Abstract] [Full-text]
239. Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer.
     Surgery, 141(5): 645-53. [Abstract] [Full-text]
240. Lymph node axillary metastasis from occult contralateral infiltrating lobular carcinoma arising in accessory breast: MRI diagnosis.
     Breast J, 13(3): 305-7. [Abstract] [Full-text]
241. An unusual presentation of locally recurrent breast cancer: a case report.
     Breast J, 13(3): 294-6. [Abstract] [Full-text]
242. Safety of elective hand surgery following axillary lymph node dissection for breast cancer.
     Breast J, 13(3): 287-90. [Abstract] [Full-text]
243. Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage.
     Breast J, 13(3): 281-6. [Abstract] [Full-text]
244. Phase I/II trial of adjuvant dose-dense docetaxel/epirubicin/cyclophosphamide (TEC) in stage II and III breast cancer.
     Breast J, 13(3): 274-80. [Abstract] [Full-text]
245. Breast edema in patients undergoing breast-conserving treatment for breast cancer: assessment via high frequency ultrasound.
     Breast J, 13(3): 266-73. [Abstract] [Full-text]
246. Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year.
     Breast J, 13(3): 258-65. [Abstract] [Full-text]
247. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
     Breast J, 13(3): 251-7. [Abstract] [Full-text]
248. Neoadjuvant use of endocrine therapy in breast cancer.
     Breast J, 13(3): 243-50. [Abstract] [Full-text]
249. Body image score following anterior and lateral approaches to wide local excision for early breast cancer.
     Breast J, 13(3): 238-42. [Abstract] [Full-text]
250. Factors determining adequacy of axillary node dissection in breast cancer patients.
     Breast J, 13(3): 233-7. [Abstract] [Full-text]
251. Chemoselective probes for metabolite enrichment and profiling.
     Nat Methods, 4(5): 429-35. [Abstract] [Full-text]
252. Active and passive cigarette smoke and breast cancer survival.
     Ann Epidemiol, 17(5): 385-93. [Abstract] [Full-text]
253. Biomarkers for early detection of breast cancer: what, when, and where?
     Biochim Biophys Acta, 1770(6): 847-56. [Abstract] [Full-text]
254. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
     Am J Epidemiol, 165(10): 1187-98. [Abstract] [Full-text]
255. ACR Appropriateness Criteria on palpable breast masses.
     J Am Coll Radiol, 4(5): 285-8. [Abstract] [Full-text]
256. Tubal sterilization, all-cause death, and cancer among women in the United Kingdom: evidence from the Royal College of General Practitioners' Oral Contraception Study.
     Am J Obstet Gynecol, 196(5): 447.e1-8. [Abstract] [Full-text]
257. Breast cancer knowledge, attitudes, and screening behaviors among African American women: the Black cosmetologists promoting health program.
     BMC Public Health, 7: 57. [Abstract] [Full-text]
258. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.
     J Biol Chem, 282(18): 13326-33. [Abstract] [Full-text]
259. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3.
     J Biol Chem, 282(18): 13316-25. [Abstract] [Full-text]
260. Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD.
     Int J Cancer, 121(1): 211-15. [Abstract] [Full-text]
261. Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands.
     Int J Cancer, 121(1): 127-35. [Abstract] [Full-text]
262. The amplified WWP1 gene is a potential molecular target in breast cancer.
     Int J Cancer, 121(1): 80-87. [Abstract] [Full-text]
263. Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer.
     Int J Cancer, 121(1): 165-74. [Abstract] [Full-text]
264. Rapamycin together with herceptin significantly increased anti-tumor efficacy compared to either alone in ErbB2 over expressing breast cancer cells.
     Int J Cancer, 121(1): 157-64. [Abstract] [Full-text]
265. BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR.
     Int J Cancer, 121(1): 39-46. [Abstract] [Full-text]
266. Proliferation of human breast cancer cells and anti-cancer action of doxorubicin and vinblastine are independent of PKC-alpha.
     J Cell Biochem, 101(2): 517-28. [Abstract] [Full-text]
267. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
     Eur J Obstet Gynecol Reprod Biol, 132(1): 101-6. [Abstract] [Full-text]

© 2004-2008 Breast Cancer Research Today. All Rights Reserved.